Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Taylor

Showing results (31-40 of 165) with videos related to

Pageof 17
Sort By:
Thorax|September 1, 1995
Asthma morbidity and mortality in New ZealandD R Taylor, C S Wong
Respirology (Carlton, Vic.)|April 27, 2010
Defining the role of exhaled nitric oxide measurements in COPDJack F Dummer, D R Taylor
The New Zealand Medical Journal|September 29, 2000
Inhaled steroids for chronic obstructive pulmonary disease--where are we now?D R Taylor, C S Wong
Thorax|June 17, 2000
Interactions between corticosteroids and beta agonistsD R Taylor, R J Hancox
Acta Tropica|December 1, 1991
Differentiation and limited proliferation of isolated Leishmania mexicana amastigotes at 27 degrees CD R Taylor, G T Williams
Drug Safety|October 1, 1994
The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiologyM R Sears, D R Taylor
The American Review of Respiratory Disease|March 1, 1992
Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthmaM R Sears, D R Taylor
The European Respiratory Journal|July 1, 1992
Regular beta-agonist therapy--the quality of the evidenceM R Sears, D R Taylor
The European Respiratory Journal|August 13, 1999
Beta2-agonist enantiomers: is there a glitch with the chiral switch?J P Fawcett, D R Taylor
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroidsR J Hancox, D R Taylor
Pageof 17

Showing results (31-40 of 165) with videos related to

Sort By:
Pageof 17
Thorax|September 1, 1995
Asthma morbidity and mortality in New ZealandD R Taylor, C S Wong
Respirology (Carlton, Vic.)|April 27, 2010
Defining the role of exhaled nitric oxide measurements in COPDJack F Dummer, D R Taylor
The New Zealand Medical Journal|September 29, 2000
Inhaled steroids for chronic obstructive pulmonary disease--where are we now?D R Taylor, C S Wong
Thorax|June 17, 2000
Interactions between corticosteroids and beta agonistsD R Taylor, R J Hancox
Acta Tropica|December 1, 1991
Differentiation and limited proliferation of isolated Leishmania mexicana amastigotes at 27 degrees CD R Taylor, G T Williams
Drug Safety|October 1, 1994
The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiologyM R Sears, D R Taylor
The American Review of Respiratory Disease|March 1, 1992
Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthmaM R Sears, D R Taylor
The European Respiratory Journal|July 1, 1992
Regular beta-agonist therapy--the quality of the evidenceM R Sears, D R Taylor
The European Respiratory Journal|August 13, 1999
Beta2-agonist enantiomers: is there a glitch with the chiral switch?J P Fawcett, D R Taylor
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
Long-acting beta-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroidsR J Hancox, D R Taylor
Pageof 17